Project Grant HT94252410154
Award Date 4/1/24
Completion Date 3/31/28
Dollars Obligated $1.4M
Federal Agency
Awardee
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Rochester, MN 55905, USA
Similar Awards
- The U.S. Defense Health Agency has awarded a $1,187,875 Project Grant to Mayo Clinic to support the research project "INVESTIGATING MOLECULAR MECHANISMS UNDERLYING THE CILIARY TRAFFICKING OF POLYCYSTINS". This grant, awarded on April 1, 2024 under the Military Medical Research and Development program (CFDA 12.420), will fund research to advance the understanding of the molecular mechanisms involved in the trafficking of polycystins through cellular cilia. The project aims to yield...
- The federal Project Grant award of $161,400.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) will support Mayo Clinic's research project titled "AN ATLAS OF THE TUMOR IMMUNE CIRCULOME." This award, with a performance period from June 1, 2024 to May 31, 2025, aims to advance medical knowledge and improve patient care through innovative biomedical research. The Military Medical Research and Development program funds a wide range of...
- Mayo Clinic was awarded a $8,966,819 project grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will support research from July 1, 2023 to June 30, 2027 to further develop purified exosome products for treating pulmonary damage from toxic exposures, leveraging Mayo Clinic's expertise in exosome applications. Through this funding, Mayo Clinic aims to advance biomedical solutions applicable to both military and civilian...
- The Defense Health Agency awarded a $736,006 Project Grant to the Mayo Clinic in Rochester, MN to conduct a Phase 1 clinical trial of a biologically engineered growing heart conduit for the repair of discontinuous pulmonary arteries. The grant, funded under the Military Medical Research and Development program (CFDA 12.420), will support advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The clinical trial will develop an...
- The Defense Health Agency awarded Mayo Clinic Jacksonville $3,232,027 under the Military Medical Research and Development federal grant program (CFDA 12.420) from September 15, 2023 through September 14, 2027. Through this award, Mayo Clinic will integrate molecular pathology, radiology, and genetics to improve breast cancer risk prediction. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform health care for service members...
- The Defense Health Agency awarded a $152,192 Project Grant to Mayo Clinic in Rochester, MN under the Military Medical Research and Development program (CFDA 12.420) to develop a novel approach for the noninvasive molecular classification of kidney cancer using tumor-derived extracellular vesicles. The grant, with a performance period from November 1, 2025 to October 31, 2026, supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the...
- The Department of Defense's Defense Health Agency awarded a $322,800 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Mayo Clinic in Rochester, Minnesota. The grant, with a performance period from April 1, 2024 to March 31, 2026, supports research on "MYELOPEROXIDASE PROMOTES PERSISTENT FIBROSIS." As a renowned non-profit academic medical center, Mayo Clinic will leverage its expertise in clinical care, biomedical research, and medical...
- This federal Project Grant award of $1,782,155 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by the Mayo Clinic to identify novel drug targets for lethal prostate cancer using liquid biopsy. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative medical solutions to critical health challenges. The award, with a performance period from April 1,...
- This federal Project Grant award of $424,565.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports advanced biomedical research at the Mayo Clinic in Rochester, Minnesota. The research aims to investigate the clinical significance of somatic genetic variants in telomere biology disorders. This grant, with a performance period from September 1, 2025 to August 31, 2028, contributes to the Defense Health Agency's broader...
- This $564,900.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research by Mayo Clinic in Rochester, MN. The project, titled "Targeting the Distinct Immune Microenvironments of Intrahepatic and Perihilar/Distal Cholangiocarcinoma," aims to transform healthcare for military service members, veterans, and the broader public through innovative and impactful research on a rare form...